Deciphering the emergence of mutations in Pseudomonas aeruginosa after ceftolozane/tazobactam treatment and evaluating therapeutic alternatives

Abstract Objectives Ceftolozane/tazobactam is a relevant option for treating multiresistant Pseudomonas aeruginosa, a major public health problem. Over a 14-month period, we studied the frequency of ceftolozane/tazobactam resistance development and mechanisms underlying resistance in P. aeruginosa i...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Léa Bientz, Hugo Boijout, Raoudha Grami, Ulysse Guyet, Marin Lahouati, Melissande Hertzmann, Antony Marques, Audrey Toirot, Sabine Aillerie, Laure Coulange-Mayonnove, Alexis Groppi, Macha Nikolski, Cécile Bébéar, Véronique Dubois
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2025-12-01
Sarja:	BMC Microbiology
Aiheet:	Pseudomonas aeruginosa Multidrug resistance Ceftolozane/tazobactam Cephalosporinase New antibiotics
Linkit:	https://doi.org/10.1186/s12866-025-04517-z
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!